发明名称 Ny fremgangsmate for nedregulering av amyloid
摘要 The present invention provides for novel immungens that are comprised of an activated polyhydroxypolymer backbone to which is attached 2 separate antigenic determinants. The 1st antigenic determinant includes a B-cell or CTL epitope and the 2nd antigenic determinant includes a T-helper epitope. In preferred embodiments, the antigenic determinants are derived from different molecules and species. Exemplary immunogens of the invention are constituted of a linear tresyl-activated dextran backbone to which is coupled B-cell or CTL epitopes of an antigen and to which is also coupled universal T-helper epitopes. Also disclosed are immunogenic compositions comprising the immunogens, methods of immunisation and a mehtod for identification of suitable immunogens of the invention.
申请公布号 NO20040431(A) 申请公布日期 2004.04.16
申请号 NO20040000431 申请日期 2004.01.30
申请人 PHARMEXA A/S 发明人 JENSEN MARTIN ROLAND;NIELSEN KLAUS GREGORIUS;RASMUSSEN PETER BIRK;KOEFOED PETER;DEGAN FLORENCE DAL
分类号 A61K;A61K39/00;A61K39/10;A61K39/385;A61P;C07K;(IPC1-7):A61K39/00 主分类号 A61K
代理机构 代理人
主权项
地址